SCHEMBL16085608

SCHEMBL16085608

O=C(Nc1ncc(Cc2ccc(C(F)(F)F)cc2)s1)c1cccc(P)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 7/20 0.56
▸ MEN1 O00255 7/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ LMNA P02545 7/20 0.54
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ MAPT P10636 5/20 0.54
▸ SCD O00767 5/20 0.53
▸ NPC1 O15118 5/20 0.48
▸ RAB9A P51151 5/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ NFKB1 P19838 4/20 0.48
▸ NFKB2 Q00653 4/20 0.48
▸ RELA Q04206 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ HPGD P15428 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085429 0.85 LMNA (0.56) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085610 0.82 SCD (0.65) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085613 0.82 SCD (0.55) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085438 0.81 LMNA (0.53) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16061195 0.79 ABL1 (0.52) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085380 0.79 RAB9A (0.74) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085539 0.78 LMNA (0.57) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085487 0.77 ABL1 (0.60) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16085425 0.77 SCD (0.61) ABL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL16062238 0.77 LMNA (0.60) ABL1MEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014145642-A9 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-11-13 — — WO disclosed
WO-2014145642-A2 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-09-18 — — WO disclosed
US-8728631-B2 Dendrimer compound and organic luminescent device employing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-20 — — US disclosed
Send feedback